LOUIS - Pharsight, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, today announced the launch of Phoenix WinNonlin, the next generation of the company's industry-standard software tool for pharmacokinetic and pharmacodynamic (PK/PD) modeling and noncompartmental analysis. Phoenix WinNonlin 6.0 Provides Enhancements to Industry-Standard PK/PD Analysis Tool, Adds New Interface and Workflow Management Engine
Pharsight Launches Phoenix WinNonlin as Cornerstone of New Software Platform for Model-Based Drug Development
0 kommentar(er)
